Quick Answer
Phio Pharmaceuticals Corp. reported Total Revenue of $0.00 for fiscal year 2020.
Phio Pharmaceuticals Corp. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2020 | $0.00 | -100.0% |
| 2019 | $21.0K | -84.8% |
| 2018 | $138.0K | +820.0% |
| 2017 | $15.0K | -21.1% |
| 2016 | $19.0K | -44.1% |
| 2015 | $34.0K | -91.5% |
| 2013 | $399.0K | +311.3% |
| 2012 | $97.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2020 | $0.00 | — | — |
| June 30, 2020 | $0.00 | — | — |
| March 31, 2020 | $0.00 | -100.0% | — |
| September 30, 2019 | $0.00 | -100.0% | — |
| June 30, 2019 | $0.00 | -100.0% | -100.0% |
| March 31, 2019 | $21.0K | -8.7% | -63.2% |
| September 30, 2018 | $57.0K | — | -1.7% |
| June 30, 2018 | $58.0K | — | +152.2% |
- Phio Pharmaceuticals Corp. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- Over the 2012–2020 period, Phio Pharmaceuticals Corp.’s total revenue has declined by 100.0% (from $97.0 thousand to $0.00).
- The most recent figure is from Phio Pharmaceuticals Corp.’s fiscal year 2020 report (Form 10-K), filed with the SEC on March 25, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: